The 12th UCLA Diabetes Symposium

OverviewDiabetes poses a major healthcare challenge given its rising prevalence, cost, and risk of chronic complications and co-morbidities. Healthcare providers are required to address these concerns in a changing landscape of therapy and technology where treatments for diabetes continue to expand. The annual UCLA Diabetes Symposium is a full-day CME program offering providers of varying backgrounds a chance to review optimal state-of-the-art patient care. Experts in the field will review current best practices, including updates in care, guidelines, and new medication classes, as well as address co-morbidities including cardiovascular disease and obesity.

Registration

In-Person Attendance Fee

$175 Physicians
$150 Allied Health Professionals

Recharge Payment Information
Registration payment can be submitted via the Interdepartmental recharge system.
For more details, please refer to document here: Recharge Information.

Refunds
Cancellations must be received via email to ccpd@mednet.ucla.edu by Friday, October 25, 2024 and will be subject to a $75 processing fee. No refunds will be granted after that date. If, for any reason, the course must be cancelled, discontinued, or rescheduled a full refund will be provided.

Course Recording
The course will not be recorded.

Target Audience

Specialties - Internal Medicine

Professions - Advanced Practice Nurse, Nurse, Pharmacist, Physician, Physician Assistant

Objectives

At the conclusion of this activity, learners will be able to:

1. Counsel patients with diabetes on cardiovascular disease prevention
2. Discuss the risks and benefits of SGLT-2 Inhibitors
3. Understand the risks and benefits of Incretin (GLP-1, GIP) medications used in type 2 diabetes mellitus
4. Counsel patients on the use of diabetes technologies, including continuous glucose monitoring (CGM) devices.
5. Understand obesity co-morbidities and treatments.
6. Recognize the intersection of bone health and diabetes as well as treatment of fracture prevention.

Accreditation

The David Geffen School of Medicine at UCLA is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The David Geffen School of Medicine at UCLA designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.